Laser BurnNCT03630406
Vaginal Elasticity Assessment Before and After Vaginal Carbon Dioxide Laser Treatment.
An observational study of Laser Burn, run by Rambam Health Care Campus at 1 site in Israel.
Trial summary
Female patients with either stress urinary incontinence (SUI) or vaginal wall weakness and prolapse will be evaluated for vaginal elasticity using vaginal tactile imaging both before and after Carbon Dioxide laser treatment. Read more about this study
- Who is it for?
- Ages 18 to 75 years, women only
- Conditions the study is for
- Laser Burn
- What is being tested?
- Vaginal Tactile Imaging
- How many people
- 25 participants
- Where
- 1 siteIsrael
- Study dates
- 1 Oct 2018to 31 Aug 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- Women only
- No healthy volunteers
- Adult, Older adult
Study population: Female patients with either SUI or vaginal wall weakness and prolapse.
Who may be able to join
- Any woman undergoing vaginal Carbon Dioxide laser treatment.
Who cannot join
- Women that are not in the age range.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Vaginal Elasticity Assessment Before and After Vaginal Carbon Dioxide Laser Treatment.as Measured by Vaginal Tactile Imaging.
Female patients with either stress urinary incontinence (SUI) or vaginal wall weakness and prolapse will be evaluated for vaginal elasticity using vaginal tactile imaging both before and after Carbon Dioxide laser treatment.
Read the detailed description
Patients will be recruited and sign a consent form. The patients included are patients with SUI or vaginal wall weakness and prolapse. Each participant undergoes 3 laser treatments 4 weeks apart.
Assessment of vaginal elasticity via vaginal tactile imaging will be performed at 3 different points:
- Before the first treatment session (baseline).
- Before and after each treatment session.
- 3 months post final treatment. Every patient will serve as her own control. Demographic, gynecologic and obstetric history will be obtained from patients' electronic files.
- Conditions
- Laser Burn
- Being tested
- Vaginal Tactile Imaging
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Vaginal Tactile ImagingDiagnostic test
Vaginal Tactile Imaging
| Study group | Role | What they receive |
|---|---|---|
| Laser treatment | Female patients with either SUI of vaginal wall weakness and prolapse refered for an attempt at laser treatment. Receives: Diagnostic Test: Vaginal Tactile Imaging |
What is being measured
The primary outcome is the main question the study is designed to answer.
Vaginal elasticity assessment
Vaginal elasticity as measured by the vaginal tactile imager
Measured: up to 3 months from enrollment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Aug 2018
- Study start1 Oct 2018
- Primary completion30 Apr 2020
- Study completion31 Aug 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Laser BurnStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 25 participants (actual)
Sponsor and investigators
- Lead sponsor
- Rambam Health Care Campus
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, ROY LAUTERBACH MD, Rambam Health Care Campus
- Investigators
- Roy Lauterbach, MD, Principal investigator, Principal Investigator
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03630406
- Sponsor's protocol ID
- 0022-18-RMB
- Status last verified
- Sep 2020
- First submitted
- 10 Aug 2018
- Last updated
- 16 Sep 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Vaginal Elasticity Assessment Before and After Vaginal Carbon Dioxide Laser Treatment.as Measured by Vaginal Tactile Imaging.
- ClinicalTrials.gov ID
- NCT03630406
- Acronym / sponsor ID
- 0022-18-RMB
- Conditions
- Laser Burn
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 25 participants (actual)
- Lead sponsor
- Rambam Health Care CampusUniversity, hospital or other
- Study start
- 1 Oct 2018 (actual)
- Primary completion
- 30 Apr 2020 (actual)
- Study completion
- 31 Aug 2020 (actual)
- First posted
- 14 Aug 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Female patients with either stress urinary incontinence (SUI) or vaginal wall weakness and prolapse will be evaluated for vaginal elasticity using vaginal tactile imaging both before and after Carbon Dioxide laser treatment.
Detailed description
Patients will be recruited and sign a consent form. The patients included are patients with SUI or vaginal wall weakness and prolapse. Each participant undergoes 3 laser treatments 4 weeks apart.
Assessment of vaginal elasticity via vaginal tactile imaging will be performed at 3 different points:
- Before the first treatment session (baseline).
- Before and after each treatment session.
- 3 months post final treatment. Every patient will serve as her own control. Demographic, gynecologic and obstetric history will be obtained from patients' electronic files.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Laser treatment | – | Diagnostic Test: Vaginal Tactile ImagingFemale patients with either SUI of vaginal wall weakness and prolapse refered for an attempt at laser treatment. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Female patients with either SUI or vaginal wall weakness and prolapse.
Key inclusion criteria (1 listed)
- Any woman undergoing vaginal Carbon Dioxide laser treatment.
Key exclusion criteria (1 listed)
- Women that are not in the age range.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Vaginal Tactile ImagingVaginal Tactile Imaging | Diagnostic test | Laser treatment |
Primary outcome
Vaginal elasticity assessment
Time frame: up to 3 months from enrollment
Vaginal elasticity as measured by the vaginal tactile imager
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2020.
- Individual participant dataSharing planned: Undecided
Related trials for Laser Burn
Not yet recruiting
Carbon Dioxide Laser-Assisted Delivery of Triamcinolone With or Without 5-Fluorouracil for Hypertrophic Burn Scars
Burn, Hypertrophic Scars
Recruiting
The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars
Burn Scar
Recruiting
The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars
Burn Scar
Enrolling by invitation
CO2 Fractional Laser With Tranexamic Acid As An Effective Tool For Post Burn Hyperpigmentation.
Post Burn Hyperpigmentation
Not yet recruiting
New Pattern of Retinal Laser Treatment for PDR
Proliferative Diabetic Retinopathy, Photocoagulation Burn to Retina
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Roy Lauterbach, MD principal investigator
Principal Investigator
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Laser Burn, run by Rambam Health Care Campus at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Vaginal elasticity assessment (time frame: up to 3 months from enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2020.